TFF Pharmaceuticals Statistics
Share Statistics
TFF Pharmaceuticals has 4.44M shares outstanding. The number of shares has increased by 46.53% in one year.
| Shares Outstanding | 4.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 11.88% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.80M |
| Failed to Deliver (FTD) Shares | 475 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 171.96K, so 4.96% of the outstanding shares have been sold short.
| Short Interest | 171.96K |
| Short % of Shares Out | 4.96% |
| Short % of Float | 5.54% |
| Short Ratio (days to cover) | 1.77 |
Valuation Ratios
The PE ratio is -0.59 and the forward PE ratio is -0.45.
| PE Ratio | -0.59 |
| Forward PE | -0.45 |
| PS Ratio | 17.15 |
| Forward PS | 0.4 |
| PB Ratio | 1.32 |
| P/FCF Ratio | -0.78 |
| PEG Ratio | n/a |
Enterprise Valuation
TFF Pharmaceuticals Inc. has an Enterprise Value (EV) of 7.22M.
| EV / Earnings | -0.34 |
| EV / Sales | 9.84 |
| EV / EBITDA | -0.35 |
| EV / EBIT | -0.33 |
| EV / FCF | -0.45 |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.13 |
| Quick Ratio | 3.13 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 0.87 |
| Cash Flow / Debt | -192.05 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -2.22% and return on capital (ROIC) is -226.13%.
| Return on Equity (ROE) | -2.22% |
| Return on Assets (ROA) | -1.77% |
| Return on Capital (ROIC) | -226.13% |
| Revenue Per Employee | 38.62K |
| Profits Per Employee | -1.12M |
| Employee Count | 19 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.1% in the last 52 weeks. The beta is 1.32, so TFF Pharmaceuticals 's price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -99.1% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 2.62 |
| Relative Strength Index (RSI) | 20.19 |
| Average Volume (20 Days) | 1.45M |
Income Statement
In the last 12 months, TFF Pharmaceuticals had revenue of $733.87K and earned -$21.24M in profits. Earnings per share was $-11.85.
| Revenue | 733.87K |
| Gross Profit | 231.39K |
| Operating Income | -21.89M |
| Net Income | -21.24M |
| EBITDA | -20.74M |
| EBIT | -21.89M |
| Earnings Per Share (EPS) | -11.85 |
Balance Sheet
The company has $5.48M in cash and $115.25K in debt, giving a net cash position of $5.36M.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 115.25K |
| Net Cash | 5.36M |
| Retained Earnings | -118.33M |
| Total Assets | 7.08M |
| Working Capital | -432.35K |
Cash Flow
In the last 12 months, operating cash flow was -$16.04M and capital expenditures -$94.75K, giving a free cash flow of -$16.13M.
| Operating Cash Flow | -16.04M |
| Capital Expenditures | -94.75K |
| Free Cash Flow | -16.13M |
| FCF Per Share | -9 |
Margins
Gross margin is 31.53%, with operating and profit margins of -2.98K% and -2.89K%.
| Gross Margin | 31.53% |
| Operating Margin | -2.98K% |
| Pretax Margin | -2.89K% |
| Profit Margin | -2.89K% |
| EBITDA Margin | -2.83K% |
| EBIT Margin | -2.98K% |
| FCF Margin | -2.20K% |
Dividends & Yields
TFFP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -16928.57% |
| FCF Yield | -5586.24% |
Analyst Forecast
The average price target for TFFP is $44, which is 62757.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $44 |
| Price Target Difference | 62757.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 19, 2023. It was a backward split with a ratio of 1:25.
| Last Split Date | Dec 19, 2023 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -34.66 |
| Piotroski F-Score | 3 |